These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6874272)

  • 1. Efficacy of antifungal agents in the cornea. I. A comparative study.
    O'Day DM; Robinson R; Head WS
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1098-102. PubMed ID: 6874272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
    O'Day DM; Ray WA; Robinson R; Head WS
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):331-5. PubMed ID: 6321389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the corneal epithelium on the efficacy of topical antifungal agents.
    O'Day DM; Ray WA; Head WS; Robinson RD
    Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):855-9. PubMed ID: 6329991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of antifungal agents in the cornea. IV. Amphotericin B methyl ester.
    O'Day DM; Ray WA; Head WS; Robinson RD
    Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):851-4. PubMed ID: 6735649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo susceptibility of Candida keratitis to topical polyenes.
    O'Day DM; Ray WA; Robinson RD; Head WS; Savage AM
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):874-80. PubMed ID: 3553060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits.
    Hiraoka T; Kaji Y; Wakabayashi T; Nanbu PN; Okamoto F; Oshika T
    Cornea; 2007 Apr; 26(3):336-42. PubMed ID: 17413962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida interface keratitis after deep anterior lamellar keratoplasty: clinical, microbiologic, histopathologic, and confocal microscopic reports.
    Kanavi MR; Foroutan AR; Kamel MR; Afsar N; Javadi MA
    Cornea; 2007 Sep; 26(8):913-6. PubMed ID: 17721287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.
    Groll AH; Giri N; Petraitis V; Petraitiene R; Candelario M; Bacher JS; Piscitelli SC; Walsh TJ
    J Infect Dis; 2000 Jul; 182(1):274-82. PubMed ID: 10882607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Natamycin (pimaricin) in the treatment of experimental keratomycosis].
    Behrens-Baumann W; Klinge B
    Fortschr Ophthalmol; 1990; 87(3):237-40. PubMed ID: 2376371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental cockscomb candidiasis as a model for testing antifungal agents effective against blastomyces].
    Kramer A; Rödel R; Krause R; Weuffen W; Kühne R
    Z Gesamte Hyg; 1974; 20(8):509-12. PubMed ID: 4462317
    [No Abstract]   [Full Text] [Related]  

  • 11. [Model of experimental Candida mycosis for testing fungistatics].
    Kulikova VN; Minasian MA; Razbitskaia GT
    Veterinariia; 1979 Jan; (1):47-8. PubMed ID: 419668
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis.
    Weinstein WL; Moore PA; Sanchez S; Dietrich UM; Wooley RE; Ritchie BW
    Am J Vet Res; 2006 Apr; 67(4):562-8. PubMed ID: 16579746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
    Thaler M; Bacher J; O'Leary T; Pizzo PA
    J Infect Dis; 1988 Jul; 158(1):80-8. PubMed ID: 3392423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-infectious effect of sustained antravitreal amphotericin B drug delivery system on experimental rabbit fungal endophthalmitis of Candida albicans].
    Chen N; Yang YT; Dong XG; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2006 May; 42(5):420-5. PubMed ID: 16762236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
    Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contact lens-induced infection--a new model of Candida albicans keratitis.
    O'Day DM; Head WS; Robinson RD; Yang R; Shetlar D; Wang MX
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1607-11. PubMed ID: 10359345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida endophthalmitis: focus on current and future antifungal treatment options.
    Khan FA; Slain D; Khakoo RA
    Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture.
    Jones BR
    Am J Ophthalmol; 1975 May; 79(5):719-51. PubMed ID: 1096622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies in experimental keratomycosis.
    O'Day DM
    Curr Eye Res; 1985 Mar; 4(3):243-52. PubMed ID: 4017624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.